Iminostilbene
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Iminostilbene
Description:
Iminostilbene is a chemical precursor of carbamazepine. Additionally, Iminostilbene is an orally active inhibitor of PKM2 (Pyruvate Kinase M2) and COX2 (Cyclooxygenase-2) . Iminostilbene exerts its effects by inhibiting PKM2 and its interaction with HIF-1α and STAT3, reducing COX2 and iNOS expression, and decreasing LPS-induced release of IL-1β, IL-6, TNF-α, and MCP-1, thereby suppressing macrophage-mediated inflammatory responses and improving myocardial ischemia/reperfusion (MI/R) injury. Iminostilbene holds promise for research in inflammation regulation, cardiovascular diseases (such as MI/R injury), and macrophage-mediated immune-related diseases[1][2].UNSPSC:
12352005Hazard Statement:
H302, H401, H411Target:
COX; HIF/HIF Prolyl-Hydroxylase; Interleukin Related; NO Synthase; Pyruvate Kinase; STAT; TNF ReceptorType:
Reference compoundRelated Pathways:
Apoptosis; Immunology/Inflammation; JAK/STAT Signaling; Metabolic Enzyme/Protease; Stem Cell/WntField of Research:
Inflammation/Immunology; Cardiovascular DiseaseAssay Protocol:
https://www.medchemexpress.com/iminostilbene.htmlPurity:
99.34Solubility:
DMSO : 50 mg/mL (ultrasonic)Smiles:
C12=CC=CC=C1C=CC3=CC=CC=C3N2Molecular Formula:
C14H11NMolecular Weight:
193.25Precautions:
H302, H401, H411References & Citations:
[1]Christian P, et al. Crystallization of Carbamazepine in Proximity to Its Precursor Iminostilbene and a Silica Surface. Cryst Growth Des. 2016 May 4;16 (5) :2771-2778. Epub 2016 Mar 30.|[2]Lu S, et al. Iminostilbene, a novel small-molecule modulator of PKM2, suppresses macrophage inflammation in myocardial ischemia-reperfusion injury. J Adv Res. 2020 Sep 9;29:83-94.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, protect from light)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
COX-2; HIF-1α; iNOS; STAT3CAS Number:
[256-96-2]
